newsfilter
← Latest News
GlobeNewswire·

Aura Biosciences to Participate in Upcoming Investor Conferences

BOSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today